Regulation of Notch localization by endocrine therapy in Estrogen Receptor positive breast cancer cells: Clinical implications for endocrine resistance

被引：1
|
作者：
Espinoza, I. [1 ]
Caskey, M. [1 ]
Baker, R. C. [1 ]
Miele, L. [1 ]
机构：
[1] Univ Mississippi, Jackson, MS 39216 USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/0008-5472.SABCS12-P6-04-22
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-04-22
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer
    De Marchi, Tommaso
    Foekens, John A.
    Umar, Arzu
    Martens, John W. M.
    [J]. DRUG DISCOVERY TODAY, 2016, 21 (07) : 1181 - 1188
  • [2] microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
    Erin W. Howard
    Xiaohe Yang
    [J]. Biological Procedures Online, 2018, 20
  • [3] microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
    Howard, Erin W.
    Yang, Xiaohe
    [J]. BIOLOGICAL PROCEDURES ONLINE, 2018, 20
  • [4] Estrogen receptor gene fusions drive endocrine therapy resistance in estrogen receptor positive breast cancer
    Lei, Jonathan T.
    Shao, Jieya
    Zhang, Jin
    Iglesia, Michael
    Chan, Doug W.
    Matsunuma, Ryoichi
    He, Xiaping
    Singh, Purba
    Kosaka, Yoshimasa
    Crowder, Robert
    Haricharan, Svasti
    Kavuri, Shyam
    Hoog, Jeremy
    Phommaly, Chanpheng
    Goncalves, Rodrigo
    Romalho, Susana
    Lai, Wei-Chu
    Hampton, Oliver
    Rogers, Anna
    Tobias, Ethan
    Parikh, Poojan
    Davies, Sherri
    Ma, Cynthia
    Suman, Vera
    Hunt, Kelly
    Watson, Mark
    Hoadley, Katherine A.
    Thompson, Aubrey
    Perou, Charles
    Creighton, Chad J.
    Maher, Chris
    Ellis, Matthew J.
    [J]. CANCER RESEARCH, 2017, 77
  • [5] Mismatch repair defects and endocrine therapy resistance in estrogen receptor positive breast cancer
    Haricharan, Svasti
    Schmelz, Jacob
    Schmidt, Cheryl
    Singh, Purba
    Holloway, Kimberly R.
    Anurag, Meenakshi
    Li, Shunqiang
    Kavuri, Shyam M.
    Huang, Shixia
    Edwards, Dean P.
    Suman, Vera
    Hunt, Kelly
    Olson, John A.
    Hoog, Jeremy
    Ma, Cynthia X.
    Bainbridge, Matthew N.
    Ellis, Matthew J.
    [J]. CANCER RESEARCH, 2017, 77
  • [6] Inhibition of AKT abrogates resistance to endocrine therapy in estrogen receptor positive breast cancer
    Fox, Emily M.
    Davies, Barry R.
    Arteaga, Carlos L.
    [J]. CANCER RESEARCH, 2012, 72
  • [7] Vandetanib to Overcome Endocrine Resistance in Estrogen Receptor Positive Breast Cancer
    Kakati, Rasha
    Whitman, Austin A.
    Kim, Hyunsoo
    Molina, Sarahi G.
    Beltran, Adriana S.
    Spanheimer, Philip M.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2022, 235 (05) : S6 - S7
  • [8] Endocrine resistance and epigenetic reprogramming in estrogen receptor positive breast cancer
    Dimitrakopoulos, Foteinos-Ioannis
    Kottorou, Anastasia
    Tzezou, Aspasia
    [J]. CANCER LETTERS, 2021, 517 : 55 - 65
  • [9] The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer
    Rodriguez, David
    Ramkairsingh, Marc
    Lin, Xiaozeng
    Kapoor, Anil
    Major, Pierre
    Tang, Damu
    [J]. CANCERS, 2019, 11 (07)
  • [10] Regulation of Bcl-2 Family Proteins in Estrogen Receptor-Positive Breast Cancer and Their Implications in Endocrine Therapy
    Kawiak, Anna
    Kostecka, Anna
    [J]. CANCERS, 2022, 14 (02)
12345